AiViva BioPharma, Inc.
AiViva BioPharma is a clinical-stage biotech company developing first-in-class and best-in-class therapies using a localized, targeted approach to disease treatment. With clinical proof-of-concept (POC) and 43 issued patents, our pipeline spans Ophthalmology, Dermatology, Oncology, and Urology—areas where we aim to transform standards of care.
Please note: we are not currently seeking Service Provider's proposals.